Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
- Status
- RECRUITING
- Phase
- PHASE1
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2